Medications Stay in Brain Longer Than Blood Tests Indicate
 

BACK

:TORONTO (CP) - How often should patients with psychiatric disorders take their medications? It's a question that may need to be re-examined following a new study by the Centre for Addiction and Mental Health.

Decisions on how often drugs need to be taken have traditionally be based on tests that measure medication levels in the blood. But the study, published in the journal Molecular Psychiatry, suggests drugs remain in the brain longer than blood levels indicate.

A single pill taken on Monday had lingering effects in the brain on Friday, even though no traces of the drug could be found in the blood, the study says.

Since the therapeutic effects of such drugs result from their effect on the brain, the study questions the sole use of blood levels to determine doses.

Researchers might come up with more efficient dosing schedules, with fewer side-effects, if they tested for drug levels in the brain instead.

"This is the first study that systematically compared the activity of medications in the brain versus the blood using brain imaging," said Dr. Shitij Kapur, an associate professor at the University of Toronto and one of the authors of the study. "These findings could have significant impact on how physicians prescribe medication for their patients in the future."

The researchers used positron emission tomography, or PET, to track drug action in the brain. They measured the levels of two common anti-psychotic medications, olanzapine and risperidone, after giving single doses to healthy volunteers and after continuous treatment with schizophrenics.

The scans showed that with both groups, drug levels remained significantly higher in the brain than in the blood. The study suggests some dosing schedules could be made less frequent, which would be "good news for patients, who generally don't enjoy having to take many pills during the course of a day," said Dr. Gary

Remington, another study author and director of the Toronto centre's schizophrenia assessment program. Remington is now looking at whether prescribing oral medications once every two or three days is just as effective as daily dosages.

 

 


Home | Our Center | Dr. Braciszewski | F.A.Q. | Discussions | News | Links | Email Us

Web Site Design and Maintained by: Web Weavers, Inc.
All Rights Reserved

Web Site Links Disclaimer: At certain places in this site, links to other web sites can be accessed. Links to other Internet sites are provided as a convenience only. These sites contain information created, published, and maintained by organizations independent of AARC,Inc..
We do not endorse, approve, certify or control these web sites or the opinions, information, products or services contained therein, and do not guarantee the accuracy, completeness, efficacy or timeliness of information located therein, or at any link contained in a linked site. Internet locations change frequently, so many of the links provided on this web site may no longer access the external web sites listed herein.

No Medical Advice: The information posted here is not intended to be and should not be considered medical advice, as it is designed to support, not replace, the relationship that exists between a patient and his or her existing healthcare provider. It is not a substitute for the professional medical advice, diagnosis or treatment provided by your physician, other qualified health provider or any information included by the manufacturer with or on any product. Never disregard professional medical advice or delay in seeking it because of something you have read on or through the AARC web site. If you think you may have a medical emergency, call your doctor or 911 immediately.
YOU SHOULD ALWAYS CONSULT A PHYSICIAN OR OTHER HEALTHCARE PROVIDER OF YOUR OWN CHOICE AND CAREFULLY READ ALL PACKAGING AND OTHER INFORMATION PROVIDED BY THE MANUFACTURER OF ANY MEDICAL PRODUCTS OR DEVICES BEFORE USING THEM.